• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
TANG Linfang, ZHANG Ziqiang, SU Rina, HE Shuwang, YAO Jing. Advances in taste-masking technology of oral paediatric medicine[J]. Journal of China Pharmaceutical University, 2017, 48(2): 135-141. DOI: 10.11665/j.issn.1000-5048.20170202
Citation: TANG Linfang, ZHANG Ziqiang, SU Rina, HE Shuwang, YAO Jing. Advances in taste-masking technology of oral paediatric medicine[J]. Journal of China Pharmaceutical University, 2017, 48(2): 135-141. DOI: 10.11665/j.issn.1000-5048.20170202
shu

Advances in taste-masking technology of oral paediatric medicine

More Information
    Graphical Abstract
    • Abstract
  • As children are extremely sensitive to the bad taste of medicine, they have poor compliance with the bitter medicine. It is of great importance to develop the approaches of taste masking for the research of paediatric drug formulations. Besides, taste masking technology is one of the main barrier to develop children pharmaceutic preparation. This article provides an overview of the advance in taste masking technology of oral paediatric medicine in recent years, and introduces five types of taste masking technology in terms of drug, preparation and the bitter taste transduction, including principle and characteristics of these approaches, as well as their application in formulations, so as to provide some references for the development of paediatric medicine.
    • FullText(HTML)
    • References (39)
  • [1]
    Liu XY,Liu YQ.Study of a masking method to dispel the bitterness of macrolide-antibiotics and its application to prescriptions[J].J Peking Univ(北京大学学报),1997,29(3):236-237.
    [2]
    Rider K,Stoss P.Vincamine saccharinate and a pharmaceutical composition containing it dissolved therein: US,4362730A[P].1982-12-07[2016-11-24] .
    [3]
    Kugelmann H.Pharmaceutical tramadol salts: US,6723343B2[P].2004-04-20[2016-11-24] .
    [4]
    Ogata T,Koide A,Kinoshita M,et al.Taste masking of propive-rine hydrochloride by conversion to its freenbase[J].Chem Pharm Bull,2012,60(8):976-984.
    [5]
    Oksche A, Heath W, Holden T, et al. Buprenorphine-wafer for drug substitution therapy: US,9370512B2[P].2016-06-21[2016-11-24] .
    [6]
    Aman RM,Meshali MM,Abdelghani GM.Ion-exchange complex of famotidine:sustained release and taste masking approach of stable liquid dosage form[J].Drug Discov Ther,2014,8(6):268-275.
    [7]
    Sivaneswari S, Karthikeyan E, Veena D, et al. Physiochemical characterization of taste masking levetiracetam ion exchange resinates in the solid state and formulation of stable liquid suspension for pediatric use[J].Beni-Suef Univ J Basic Appl Sci,2016,5(2):126-133.
    [8]
    Rajesh AM,Bhatt SA,Brahmbhatt H,et al.Taste masking of ciprofloxacin by ion-exchange resin and sustain release at gastric-intestinal through interpenetrating polymer network[J].Asian J Pharm Sci,2015,10(4):331-340.
    [9]
    Kaushik D,Dureja H.Central composite designed taste masked ion exchange resinates for development of azithromycin dispersible tablets[J].J Pharm Res,2015,14(1):7-14.
    [10]
    Puttewar TY,Kshirsagar MD,Chandewar AV,et al.Formulation andevaluation of orodispersible tablet of taste masked doxylamine succinate usingion exchange resin[J].King Saudi Univ Sci,2010,22(4):229-240.
    [11]
    Dungarwal UN,Patil SB.Development of orodispersible tablets of taste masked rizatriptan benzoate using hydroxypropyl β cyclodextrin[J].J Pharm Investig,2016,46(6):537-545.
    [12]
    Prabhakaran R,Harindran J.Formulation and evaluation of taste masked oral suspension of cefuroxime axetil using hydroxypropyl-beta-cyclodextrin[J].Asian J Pharm Clin Res,2016,9(2):279-285.
    [13]
    Wei Y,Nedley MP,Bhaduri SB,et al.Masking the bitter taste of injectable lidocaine HCl formulation for dental procedures[J].AAPS Pharmscitech,2014,16(2):1-11.
    [14]
    Xue LI,Guo Z,Hao JB,et al.Synergetic taste masking of lipid coating and β-cyclodextrin inclusion[J].Acta Pharm Sin(药学学报),2014,49(3):392-398.
    [15]
    Ono N,Miyamoto Y,Ishiguro T,et al.Reduction of bitterness of antihistaminic drugs by complexation with β-cyclodextrins[J].J Pharm Sci,2011,100(5):1935-1943.
    [16]
    Nishiyama T,Ogata T,Ozeki T.Preparation of bitter taste-masking granules of lafutidine for orally disintegrating tablets using water-insoluble/soluble polymer combinations[J].Drug Deliv Sci Tec,2016,32:38-42.
    [17]
    Brniak W,Ma'slak E,Jachowicz R.Orodispersible films and tablets with prednisolone microparticles[J].Eur J Pharm Sci,2015,75:81-90.
    [18]
    Paik DH,Jeong KY,Kim JH,et al.Edible HPMC films with indomethacin/HPMCP microparticles in oral delivery for taste-masking[J].Macromol Res,2014,22(11):1156-1159.
    [19]
    Kondo K, Niwa T, Ozeki Y, et al. Preparation and evaluation of orally rapidly disintegrating tablets containing taste-masked particles using one-step dry-coated tablets technology[J].Chem Pharm Bull,2011,59(10):1214-1220.
    [20]
    Petrovick GF,Breitkreutz J,Pein-Hackelbusch M.Taste-masking properties of solid lipid based micropellets obtained by cold extrusion-spheronization[J].Int J Pharm,2016,506(1):361-370.
    [21]
    Refaat A,Sokar M,Ismail F,et al.A dual strategy to improve psychotic patients′ compliance using sustained release quetiapine oral disintegrating tablets[J].Acta Pharmaceut,2016,66:515-531.
    [22]
    El-Refaie WM,El-Massik MA,Abdallah OY,et al.Formulation and evaluation of taste-masked paracetamol-lipid sachets and chewable tablets[J].J Pharm Investig,2014,44(6):431-442.
    [23]
    Kharb V,Saharan VA,Kharb V,et al.Formulation and evaluation of lipid based taste masked granules of ondansetron HCl[J].Eur J Pharm Sci,2014,62(4):180-188.
    [24]
    Jaggupilli A,Howard R,Upadhyaya JD,et al.Bitter taste receptors:Novel insights into the biochemistry and pharmacology[J].Int J Biochem Cell B,2016,77:184-196.
    [25]
    Pydi SP,Jaggupilli A,Nelson KM,et al.Abscisic acid acts as a blocker of the bitter taste G protein-coupled receptor T2R4[J].Biochemistry,2015,54(16):2622-2631.
    [26]
    Mancuso G,Borgonovo G,Scaglioni L,et al.Phytochemicals from rutagraveolensactivate TAS2R bitter taste receptors and TRP channels involved in gustation and nociception[J].Molecules,2015,20(10):18907-18922.
    [27]
    Pydi S P,Sobotkiewicz T,Billakanti R,et al.Amino acid derivatives as bitter taste receptor(T2R)blockers[J].J Biol Chem,2014,289(36):25054-25066.
    [28]
    Roland WS,Gouka RJ,Gruppen H,et al.6-methoxyflavanones as bitter taste receptor blockers for hTAS2R39[J].PLoS ONE,2014,9(4):e94451-e94451.
    [29]
    Slack JP,Brockhoff A,Batram C,et al.Modulation of bitter taste perception by a small molecule hTAS2R antagonist[J].Curr Biol,2010,20(12):1104-1109.
    [30]
    Jaggupilli A,Howard R,Upadhyaya JD,et al.Bitter taste receptors:novel insights into the biochemistry and pharmacology[J].Int J Biochem Cell Biol,2016,77:184-196.
    [31]
    Deshpande DA, Wang WCH, Mcilmoyle EL, et al.Bitter taste receptors on airway smooth muscle bronchodilate by a localized calcium flux and reverse obstruction[J].Nat Med,2010,16(11):1299-1304.
    [32]
    Gu F, Liu X, Liang J, et al. Bitter taste receptor mTas2r105 is expressed in small intestinal villus and crypts[J].Biochem Bioph Res Co,2015,463(4):934-941.
    [33]
    Margolskee RF. Molecular mechanisms of bitter and sweet taste transduction[J].J Biol Chem,2002,277(1):1-4.
    [34]
    Ming D,Margolskee RF.Blocking taste receptor activation of gustducin inhibits gustatory responses to bitter compounds[J].PNAS,1999,96(17):9903-9908.
    [35]
    Min JK,Son HJ,Kim Y,et al.Umami-bitter interactions:the suppression of bitterness by umami peptides via human bitter taste receptor[J].Biochem Bioph Res Co,2014,456(2):586-90.
    [36]
    Keast RSJ,Breslin PAS.Modifying the bitterness of selected oral pharmaceuticals with cation and anion series of salts[J].Pharm Res,2002,19(7):1019-1026.
    [37]
    Riemer JA.Bitterness inhibitors: US,5336512A[P].1994-08-09[2016-11-25] .
    [38]
    Cui MM,Ji GQ,Zheng JX.Inhibition effect of ferulic acid on bitterness[J].China Food Addit(中国食品添加剂),2013(1):170-174.
    [39]
    Mennella JA,Reed DR,Roberts KM,et al.Age-related differences in bitter taste and efficacy of bitter blockers[J].PLoS ONE,2013,9(7):e103-107.
    • Related Articles

  • Related Articles

    [1]WANG Chi, TIAN Hong, GAO Xiangdong, YAO Wenbing. Influence of ubiquitous chromatin opening element on the antibody expression in CHO cells[J]. Journal of China Pharmaceutical University, 2017, 48(1): 96-101. DOI: 10.11665/j.issn.1000-5048.20170115
    [2]BI Lei, GAO Jing, JIANG Yucui, CHEN Yingna, CHEN Weiping. Effect of Ginseng, Ginseng polysaccharides and Ginsenoside on the human lung cancer cells A549 in co-culture system of TAMs with A549 cells[J]. Journal of China Pharmaceutical University, 2016, 47(6): 744-748. DOI: 10.11665/j.issn.1000-5048.20160619
    [3]LIU Su, TIAN Hong, WANG Chi, YAO Wenbing. Weakening resistance marker for establishing a process of screening high-producing CHO cell lines[J]. Journal of China Pharmaceutical University, 2015, 46(5): 617-622. DOI: 10.11665/j.issn.1000-5048.20150517
    [4]WANG Xinning, XU Bin, ZHOU Jinpei, ZHANG Huibin. Advances of anti-diabetic drugs based on new targets[J]. Journal of China Pharmaceutical University, 2015, 46(2): 141-152. DOI: 10.11665/j.issn.1000-5048.20150202
    [5]GAO Yuan, ZHAO Yue, YAO Jing, WANG Yu, GUO Qinglong, WU Yulin. Wogonin suppresses human alveolar adenocarcinoma cell A549 invasion and metastasis induced by IL-6[J]. Journal of China Pharmaceutical University, 2014, 45(4): 456-461. DOI: 10.11665/j.issn.1000-5048.20140413
    [6]MENG Yu-han, LIU Su-li, ZHANG Hui-yong, CAO Rong-yue, FAN Xiao-xu, FAN Hao, LIU Jing-jing. Construction,expression and activity studies of recombinant GFP-VEGF6a fusion polypeptide[J]. Journal of China Pharmaceutical University, 2011, 42(1): 83-87.
    [7]SHI Wei, SUN Li, LIN Sen-sen, YUAN Sheng-tao, ZHANG Lu-yong. Construction of eukaryotic expression plasmid for human TF full-length，TF truncated and characterization of their biological function[J]. Journal of China Pharmaceutical University, 2009, 40(5): 465-470.
    [8]GUO Zhong, ZHAO Jin, MA Jian-xiu, FU Si-wu. Effects of toxin A from Clostridium difficile on SMMC-7721 cells proliferation and apoptosis[J]. Journal of China Pharmaceutical University, 2009, 40(3): 250-253.
    [10]Effect of Lomerizine on Multidrug Resistance in Human Leukemic Cell Line K562/A02[J]. Journal of China Pharmaceutical University, 2003, (4): 70-74.

  • Cited by

    Periodical cited type(2)

    1. 杨振苹，邢体坤，宋路萍，刘伟，李艳芳，张静静. TaqMan荧光定量PCR法检测CHO细胞中外源基因拷贝数的方法建立. 中国当代医药. 2023(02): 15-19 .
    2. 瞿丽丽，丁学峰，蔡燕飞，鲁晨，李华钟，金坚，陈蕴. CHO细胞基因组NW-003614092.1内稳定表达位点的发现. 中国生物工程杂志. 2022(06): 12-19 .

    Other cited types(3)

Catalog

    Get Citation
    PDF
    XML
    Article views (1231) PDF downloads (4243) Cited by(5)
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    Copyright © Journal of China Pharmaceutical University苏ICP备12050101号-2

    Address：24 Tongjia Lane, Nanjing City, Jiangsu Province （210009）Tel: 025-83271566E-mail: xuebao@cpu.edu.cn

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    Total visits：297451

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return